Prenatal diagnosis of peroxisomal D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional

Y Suzuki1, Z Zhang, N Shimozawa

  • 1Department of Pediatrics, Gifu University School of Medicine, Japan. ysuz@cc.gifu-u.ac.jp

Insights

This study reports the first prenatal diagnosis of peroxisomal D-3-hydroxyacyl-coenzyme A (CoA) dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein (D-BP) deficiency. Prenatal testing confirmed D-BP deficiency in a fetus at 16 weeks gestation.

Area of Science:

  • Biochemistry
  • Genetics
  • Peroxisomal Disorders

Background:

  • Peroxisomal D-3-hydroxyacyl-coenzyme A (CoA) dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein (D-BP) deficiency is a rare genetic disorder.
  • Prenatal diagnosis is crucial for early intervention and management.

Observation:

  • Cultured amniocytes from a 16-week fetus were analyzed using various techniques.
  • Peroxisomal beta-oxidation was significantly reduced, and large peroxisomes were observed.

Findings:

  • Immunoreactive D-BP was absent, and a specific cDNA deletion was identified, confirming D-BP deficiency.
  • Autopsy of the fetus revealed characteristic facial features and confirmed D-BP deficiency in tissues.

Implications:

  • This marks the first successful prenatal diagnosis of D-BP deficiency.
  • Early prenatal detection enables timely management strategies for affected newborns.